Discovery of a Novel Classof Highly Potent, Selective,ATP-Competitive, and Orally Bioavailable Inhibitors of the MammalianTarget of Rapamycin (mTOR).

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request